Literature DB >> 1715107

Intravenous gamma-globulin for chronic inflammatory demyelinating polyneuropathy and myasthenia gravis.

J C Keesey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1715107      PMCID： PMC1002922     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  3 in total

1.  High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study.

Authors:  P A van Doorn; A Brand; P F Strengers; J Meulstee; M Vermeulen
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

2.  High-dose intravenous immunoglobulin in the management of myasthenia gravis.

Authors:  E L Arsura; A Bick; N G Brunner; T Namba; D Grob
Journal:  Arch Intern Med       Date:  1986-07

Review 3.  Clinical uses of intravenous immunoglobulins.

Authors:  S A Berkman; M L Lee; R P Gale
Journal:  Ann Intern Med       Date:  1990-02-15       Impact factor: 25.391
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.